Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients

IsraelRecruitingPHASE3

Conditions

Amyotrophic Lateral Sclerosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • University of Alabama at Birmingham, Birmingham, Alabama, United States

  • University of Southern California, Los Angeles, California, United States

  • University of Kentucky, Lexington, Kentucky, United States

  • Johns Hopkins Medicine Brain Science Institute, Baltimore, Maryland, United States

  • Lahey Hospital and Medical Center, Burlington, Massachusetts, United States

  • University of Virginia Health System, Charlottesville, Virginia, United States

  • University Hospital Leuven (UZ Leuven), Leuven, Belgium

  • Bispebjerg Hospital, Copenhagen, Denmark

  • CHU de Angers, Angers, France

  • Groupe Hospitalier Pellegrin Tripode, Bordeaux, France

  • Hôpital neurologique Pierre Wertheimer, Bron, France

  • CHU Gabriel Montpied, Clermont-Ferrand, France

  • CHU de Lille - Hopital Roger Salengro, Lille, France

  • CHU de Limoges - Hôpital Dupuytren, Limoges, France

  • CHU de Marseille - Hôpital de la Timone, Marseille, France

  • CHRU de Montpellier - Gui de Chauliac, Montpellier, France

  • CHU de Nancy - Hopital Central, Nancy, France

  • CHU Hôpital Pasteur Nice, Nice, France

  • CHRU de Tours - Hopital Bretonneau, Tours, France

  • Department of Neurology, University of Ulm, Ulm, Germany

  • Athens Naval Hospital, Athens, Greece

  • Eginition Hospital, Athens, Greece

  • University General Hospital of Larissa, Larissa, Greece

  • General University Hospital of Patras, Rio, Greece

  • Hadassah University Hospital, Jerusalem, Israel

  • Tel-Aviv Medical Center Hôpital Sourasky (ICHILOV), Tel Aviv, Israel

  • Ospedale Civile Sant'Agostino - Estense, Baggiovara, Modena, Italy

  • ASST degli Spedali Civili di Brescia, Brescia, Italy

  • Centro Clinico NeMO Fondazione Serena Onlus, Gussago, Italy

  • Clinico Nemo Center (Centro Clinico NeMO Milano), Milan, Italy

  • IRCCS Istituto Auxologico Italiano, Milan, Italy

  • Istituti Clinici Scientifici Maugeri IRCCS, Milan, Italy

  • San Raffaele Hospital (Ospedale San Raffaele), Milan, Italy

  • University Hospital Maggiore della Carita, Novara, Italy

  • Azienda Ospedale-Università Padova, Padova, Italy

  • IRCCS Mondino Foundation, Pavia, Italy

  • University Hospital in Turin (Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino), Torino, Italy

  • Oslo University Hospital HF Ullevål, Oslo, Norway

  • Centrum Medyczne Neuromed, Bydgoszcz, Poland

  • Hospital de Santa Maria, Lisbon, Portugal

  • Moscow city clinical Hospital after V.M. Buyanov, Moscow, Russia

  • Scientific Practical Medical Center "Innovation and Health", Novosibirsk, Russia

  • Clinical Centre of Serbia, Belgrade, Serbia

  • Klinicni center Ljubljana, Ljubljana, Slovenia

  • Hospital General Universitario de Alicante, Alicante, Spain

  • Hospital Universitari de Bellvitge, Barcelona, Spain

  • Hospital Carlos III, Madrid, Spain

  • Hospital San Rafael, Madrid, Spain

  • Clinical Hospital Santiago de Compostela, Santiago de Compostela, Spain

  • Hospital Universitario y Politecnico La Fe, Valencia, Spain

  • Centralsjukhuset Karlstad (Central Hospital Karlstad), Karlstad, Sweden

  • Skåne University Hospital, Malmö, Sweden

  • Norrlands universitetssjukhus, Umeå, Sweden

  • The State Institution of Neurology, Psychiatry and Narcology of NAMS of Ukraine, Kharkiv, Ukraine

  • Medical Center of LLC Medical Center Dopomoga Plus, Kyiv, Ukraine

  • Communal Non-Profit Enterprise of Lviv Regional Council, Lviv Regional Clinical Hospital, Neurological Department, Lviv, Ukraine

Study leads
  • Albert Ludolph, MD, PhD

    Principal Investigator

    Department of Neurology, University of Ulm, Germany